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SUMMARY : We studied the independent and combined effects of recombinant 
human granulocyte colony- stimularting factor (rhG-CSF) and recombinant human 
granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on the growth and 
maturation of neutrophilic granulocytes. Absolute granulocyte numbers, cellular 
composition, and neutrophil alkailne phosphatase (NAP) activity were examined after 
normal nonphagocytic bone marrow cells were cultured for seven days with rhG-CSF, 
rhGM-CSF, and a combination of both growth factors. The numbers of band and 
segmented forms produced in the cultures containing rhGM-CSF were significantly lower 
than in control cultures or those with rhG-CSF. When both rhGM-CSF and rhG-CSF 
were in the culture total granulocyte production was highest, but the increment of band 
and segmented forms produced by rhG-CSF alone was reduced. Neutrophil alkaline 
phosphatase (NAP), an enzyme marking terminal maturation, was increased by rhG-CSF 
alone, but not by rhGM-CSF alone. Cultures containing both CSFs showed significantly 
lowered NAP activity compared to those containing rhG-CSF alone. The decrement in 
NAP activity was proportionate to the amount of rhGM-CSF added. These results indicate 
that terminal maturation-inducing effect is a property of rhG-CSF but not of rhGM-CSF. 
In the presence of both GM-CSF and G-CSF, the growth of granulocytes is maximumly 
stimulated but the terminal maturation-inducing effect of rhG-CSF is suppressed.
       INTRODUCTION 
 Three colony-stimulating factors (CSF), gran-
ulocyte-macrophage (GM)-CSF, granulocyte 
(G)-CSF and interleukin 3 (ID) are involved in 
granulopoiesis. G-CSF induces primarily 
neutrophilic granulocyte colonies, while GM-
CSF induces macrophage and eosinophil 
colonies as well. ILP shows a further diversity' 
of target cells including basophils, erythroid 
cells in the presence of erythropoietin and 
megakaryocytes. Moreover, purified human 
GM-CSF and G-CSF are known to stimulate the 
functions of nentroPhil s2' 3' 4). The differences 
in the biological effects of these CSFs on
granulocytes are poorly understood. We com-
pared the independent and combined effects 
of GM-CSF and G-CSF on the growth and 
maturation of granulocytes, total granulocyte 
number, cellular composition and neutrophil 
alkaline phosphatase (NAP) activity after liquid 
culture (7 days) of normal nonphagocytic bone 
marrow cells.
   MATERIALS AND METHODS 
 Bone marrow cells from 4 normal volunteers 
were aspirated into a heparinized syringe after 
obtaining appropriate informed consent. Light-
density cells were separated from each sample 
by Ficoll-Conray gradient centrifugation (1.077 
g/ul). Nonphagocytic cells were obtained by 
depleting the light-density cells of phagocytes 
using iron-particle phagocytosis as previously 
described'). One million nonphagocytic cells in 
1 ml of a-medium with 20% fetal bovine serum 
(FBS) were incubated in Falcon plastic Petri 
dishes (35 mm) with or without 10% diluted 
recombinant CSFs for 7 days at 37°C in a 
humidified , atmosphere of 5% CO2. Three 
concentrations (XI, X5, and X25 of maximum 
dose) of rhG-CSF6> and rhGM-CSF'> were 
prepared by diluting recombinant materials 
with a-medium containing 20% FBS. The 
maximum dose of each CSF was equivalent to 
the concentration giving a maximum colony 
number in semisolid culture. Both adherent and 
nonadherent cells were completely harvested by 
a Pasteur pipette after scraping the dishes 
gently with a rubber policeman and viable cell 
number was determined with a hemocytometer 
and trypan blue as a diluent. Average volume 
recovery was 0.9 ml per dish. Cell viability was 
at least 92% by trypan blue dye exclusion. Slides
for May-Griinwald-Giemsa staining and alkaline 
phosphatase staining were prepared from each 
dish by cytocentrifugation. The alkaline 
phosphatase stain was performed as previously 
described and the same scoring system of 
enzyme activity was used'). Using this system, 
the normal range of peripheral blood neutrophil 
alkaline phosphatase (NAP) score was from 158 
to 295. Student's paired t-test was used to assess 
statistical significance.
          RESULTS 
1. Independent and combined effects of rhG-CSF 
and rhGM-CSF on the growth and maturation 
of granulocytes 
 The number of viable cells in each sample 
was counted and the absolute number of each 
maturational compartment of granulocytes was 
calculated from a differential morphological 
analysis of May-Grunwald-Giemsa stained 
smears. The mean number of viable granu-
locytes was higher in the cultures with rhG-
CSF alone than those with rhGM-CSF alone. 
The cultures with both CSFs together yielded 
more granulocytes than those with rhG-CSF 
alone, although the difference was not 
statistically significant (Table 1). Comparison 
of cellular composition of the cultures con-
taining one or both CSFs with that contain-
ing neither disclosed that the major impact of 
rhGM-CSF alone was on production of 
myeloblasts, promyelocytes and myelocytes, 
while that of rhG-CSF alone was on production 
of metamyelocytes, band and segmented forms 
(Fig. 1). The number of myeloblasts was 
increased by rhGM-CSF alone but not by 
rhG-CSF alone. The cultures containing both 
CSFs at the highest concentrations did not show
        Table 1. Mean Viable Cell Number (X 105) 
                  Total Neutrophilic Band and
                     Granulocytes Sedmented Forms
Preincubation 5.24 ± 1.33 0.79 ± 0.41 
Wtihout CSF 6.81 ± 3.02 2.87 ± 2:00 
rhGM-CSF (250pM) 13.14 ± 6.31 0.90 ± 1.09} 
rhG-CSF (500U) 18.25± 9.06 6.27 ± 2.91 
rhGM-CSF (250pM) } 
 +rhG-CSF (500U) 21.94 ± 12.15 3.12 ± 1.80
                                       * :p<0.05
Fig. 1 Mean viable cell number of each neu-
      trophilic stage after liquid culture for 7 days 
      (n =4).
a further increment of myeloblasts. In the 
promyelocyte and myelocyte compartments, 
either CSF alone increased cell numbers and the 
culture with both CSFs showed the highest 
increment. No increment of band and seg-
mented forms was observed in the cultures with 
rhGM-CSF alone while, with rhG-CSF alone, the 
increase was remarkable. The mean absolute 
number of band and segmented forms in the 
cultures with rhGM-CSF alone was significantly 
lower than in those with rhG-CSF alone and 
even that with no CSF. The cultures containing 
both CSFs showed only a slight increase in band 
and segmented forms (Table 1). 
2. Independent and combined effects of rhG-CSF 
and rhGM CSF on NAP induction 
 Bone marrow light density nonphagocytic 
cells produced mature nentrophils without 
elavation of NAP activity after 7 days incubation 
as previously described 5). As shown in Fig. 2, 
NAP activity rose in a dose-dependent manner 
when rhG-CSF was included in the culture, 
while rhGM-CSF did not augment NAP activity.
Fig. 2 Dose dependency of neutrophil alkaline 
      phosphatse activity on rhG-CSF, rhGM-CSF 
      and their combination. The vertical line 
       indicate mean ± S. D. (n=4).
Fig. 3 Modulation by rhGM-CSF of neutrophil 
      alkaline phosphatase score and viable cell 
      number of band and segmented forms of 
      the culture with rhG-CSF (500U). The
      vertical line indicate mean ±S. D.(n=3).
When both rhG-CSF and rhGM-CSF were added 
to the culture, NAP activity was siginificantly 
lower. When the culture was incubated in the 
presence of the highest dose of rhG-CSF (500U) 
and various doses of rhGM-CSF, NAP activity 
was lower proportionately to the amount of 
rhGM-CSF in the culture. In addition, mean 
viable cell number of band and segmented forms 
revealed a similar pattern (Fig. 3).
         DISCUSSION 
 Morphological terminal maturation and NAP 
activity were both induced in vitro by rhG-CSF 
alone, while rhGM-CSF induced neither, though 
either CSF increased the total number of 
granulocytes. GM-CSF seems to play a major 
role in stimulating the growth of immature 
granulocytes but little role in inducing 
maturation. Recently, both CSFs were shown 
to increase total granulocyte production and 
mature neutrophils in vivo8' 1). However, our 
data may not be discrepant with these studies 
because other unknown maturation-inducing 
factors may also be involved in vivo. 
Interestingly, rhGM-CSF seems to inhibit the 
maturation effect of rhG-CSF when both CSFs 
act simultaneously. This result is unlikely to 
be due to simple receptor competition since in 
cultures containing both CSFs the effect of 
rhGM-CSF on the growth of immature granulo-
cytes was enhanced and the largest increment 
of total granulocyte numbers was found. 
Growth stimulation by rhGM-CSF seems to 
have priority over the maturation-inducing 
effect of rhG-CSF, probably through some 
intracellular pathway after binding receptors on 
the granulocyte membrane. Furher investi-
gations on the interaction of these factors at 
receptor and intracellular levels will provide the 
best method for clinical administration of them 
in the near future.
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